Bristol-Myers Squibb will accept for funding consideration Independent Medical Education (IME) grant proposals submitted through the Request for Proposal (RFP) process within the following disease states. As areas of interest may change periodically, please consult this website frequently.

 

Cardiovascular Bristol-Myers Squibb/Pfizer supported Cardiovascular IME Grant Requests: In accordance with the Bristol-Myers Squibb and Pfizer joint sponsorship of Independent Medical Education, providers interested in submitting funding requests in the Thrombosis Therapeutic area must be eligible to apply for grants per Pfizer policy. These types of eligible organizations include hospitals, academic medical centers, schools of nursing or pharmacy, professional societies and associations. For more information on eligibility requirements, please visit www.pfizermededgrants.com, or contact Pfizer’s Medical Education Group at 1-866-MEG-4647.

Atrial Fibrillation

Venous Thromboembolism (VTE) Thrombosis

 

Immunoscience

Rheumatoid Arthritis

 

Metabolics Bristol-Myers Squibb and AstraZeneca have joined together to support Independent Medical Education in the area of Metabolics.
Type 1 Diabetes Type 2 Diabetes

 

Oncology
Immuno-Oncology Leukemias Lung Cancer	Metastatic melanoma Multiple Myeloma Head & Neck Cancer (Puerto Rico only)

 

Virology

Hepatitis B Hepatitis C HIV/AIDS

Neuroscience United States - Please note that grant requests for Neuroscience are not being accepted at this time. Puerto Rico - Please note that grant requests are accepted only for Puerto Rico-based organizations.
Depression Schizophrenia	Autism Bipolar illness